Picture1 (4).jpg
Macerich Launches Path-Forward Plan
23 mai 2024 07h00 HE | Macerich Company
Macerich Launches Path-Forward Plan, Three-Part Strategy to Simplify the Business, Improve Operational Performance, and Reduce Leverage
Picture1 (4).jpg
CORRECTION - Macerich Announces Initial Progress in its Path Forward Strategic Plan
16 mai 2024 10h08 HE | Macerich Company
SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Macerich (NYSE: MAC), please note in the third paragraph, the amount the...
Picture1 (4).jpg
UPDATE - Macerich Announces Initial Progress in its Path Forward Strategic Plan
16 mai 2024 09h26 HE | Macerich Company
SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced...
Picture1 (4).jpg
Macerich Announces Initial Progress in its Path Forward Strategic Plan
16 mai 2024 06h00 HE | Macerich Company
SANTA MONICA, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of major retail properties in top markets, today announced...
Ascendis_FINAL_LOGO_7.23.15.png
Ascendis Pharma A/S Reports First Quarter 2019 Financial Results
30 mai 2019 16h02 HE | Ascendis Pharma A/S
– Continued execution of global endocrinology rare disease programs, following validation of TransCon™ platform in phase 3 heiGHt Trial – – R&D Day on June 26 to feature endocrinology and...